OrthoPediatrics Corp (KIDS) stock
Close on Nov 18, 2026Market cap $826.40MP/E –Yield –
Earnings
OrthoPediatrics's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.
Quarterly results
Revenue and earnings per share from each of OrthoPediatrics's earnings releases, newest first
| Quarter | Reported | Revenue | YoY | EPS | Adj. EPS | Source |
|---|---|---|---|---|---|---|
| Q4 FY2026ended Dec 31, 2026 | Feb 25, 2027Expected | – | – | – | – | – |
| Q3 FY2026ended Sep 30, 2026 | Oct 27, 2026after the close | $72.70M | +18.8% | -$0.25 | -$0.23 | Release |
| Q2 FY2026ended Jun 30, 2026 | Aug 4, 2026during market hours | $70.50M | +15.4% | -$0.30 | – | Release |
| Q1 FY2026ended Mar 31, 2026 | Apr 30, 2026during market hours | $59.40M | +13.4% | -$0.45 | -$0.42 | Release |
| Q4 FY2025ended Dec 31, 2025 | Feb 26, 2026during market hours | $61.60M | +16.9% | -$0.43 | -$0.26 | Release |
| Q3 FY2025ended Sep 30, 2025 | Oct 28, 2025during market hours | $61.20M | +12.1% | -$0.50 | -$0.24 | Release |
| Q2 FY2025ended Jun 30, 2025 | Aug 5, 2025during market hours | $61.10M | +15.7% | -$0.30 | -$0.11 | Release |
| Q1 FY2025ended Mar 31, 2025 | May 7, 2025during market hours | $52.40M | +17.2% | -$0.46 | -$0.39 | Release |
| Q4 FY2024ended Dec 31, 2024 | Mar 4, 2025during market hours | $52.70M | +40.2% | -$0.69 | -$0.29 | Release |
| Q3 FY2024ended Sep 30, 2024 | Nov 6, 2024during market hours | $54.60M | +36.5% | -$0.34 | -$0.18 | Release |
| Q2 FY2024ended Jun 30, 2024 | Aug 5, 2024during market hours | $52.80M | +33.3% | -$0.26 | -$0.23 | Release |
| Q1 FY2024ended Mar 31, 2024 | May 6, 2024during market hours | $44.70M | +41.5% | -$0.34 | -$0.30 | Release |
| Q4 FY2023ended Dec 31, 2023 | Mar 6, 2024during market hours | $37.60M | +21.3% | -$0.29 | -$0.22 | Release |
| Q3 FY2023ended Sep 30, 2023 | Nov 6, 2023during market hours | $40.00M | +14.3% | -$0.20 | -$0.13 | Release |
| Q2 FY2023ended Jun 30, 2023 | Jul 31, 2023during market hours | $39.60M | +20.4% | -$0.13 | -$0.19 | Release |
| Q1 FY2023ended Mar 31, 2023 | May 1, 2023during market hours | $31.60M | +35.0% | -$0.30 | -$0.29 | Release |
| Q4 FY2022ended Dec 31, 2022 | Feb 28, 2023during market hours | $31.00M | +25.0% | -$0.35 | -$0.32 | Release |
| Q3 FY2022ended Sep 30, 2022 | Oct 31, 2022during market hours | $35.00M | +39.4% | $0.87 | -$0.05 | Release |
| Q2 FY2022ended Jun 30, 2022 | Aug 3, 2022during market hours | $32.90M | – | -$0.02 | -$0.17 | Release |
| Q1 FY2022ended Mar 31, 2022 | May 4, 2022during market hours | $23.40M | – | -$0.47 | -$0.30 | Release |
| Q4 FY2021ended Dec 31, 2021 | Mar 2, 2022during market hours | $24.80M | – | – | -$0.24 | Release |
| Q3 FY2021ended Sep 30, 2021 | Nov 3, 2021during market hours | $25.10M | – | -$0.11 | -$0.15 | Release |
| Q2 FY2021ended Jun 30, 2021 | Aug 4, 2021during market hours | – | – | – | – | Filing |
| Q1 FY2021ended Mar 31, 2021 | May 5, 2021during market hours | – | – | – | – | Filing |
| Q4 FY2020ended Dec 31, 2020 | Mar 10, 2021during market hours | – | – | – | – | Filing |
| Q3 FY2020ended Sep 30, 2020 | Nov 4, 2020during market hours | – | – | – | – | Filing |
Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.
Current guidance
OrthoPediatrics's latest outlook for periods it has not reported yet, compared with what it said before
| Metric | Period | Guidance | Before | Change | Given |
|---|---|---|---|---|---|
| growth over 2025 revenue | FY2026 | +12% – +14% | +11% – +13% | Raised | Aug 4, 2026 |
| revenue guidance | FY2026 | $270.00M – $273.00M | $262.00M – $266.00M | Raised | Oct 27, 2026 |
| revenue guidance | FY2026 | $265.00M – $269.00M | $263.00M – $267.00M | Raised | Aug 4, 2026 |
| adjusted EBITDAnon-GAAP | FY2026 | $25.00M | $25.00M | Reaffirmed | Oct 27, 2026 |
| adjusted EBITDAnon-GAAP | FY2026 | $25.00M | $25.00M | Reaffirmed | Aug 4, 2026 |
| annual set deployment | FY2026 | $10.00M | – | New | Aug 4, 2026 |
| annual set deployment | FY2026 | $10.00M | – | New | Feb 26, 2026 |
| annual set deployment | FY2026 | $10.00M | – | New | Oct 27, 2026 |
| annual set deployment | FY2026 | $10.00M | – | New | Apr 30, 2026 |
Guidance vs results
The last range OrthoPediatrics gave before each report, against the figure it then reported. Full years add up the four quarters.
| Period | Metric | Guidance | Actual | Result |
|---|---|---|---|---|
| FY2025 | Revenue | $233.50M – $234.50M | $236.30MΣ4Q | Above range |
| FY2025 | Revenue growth | +14% – +15% | +15.38%Σ4Q | Above range |
Guidance history
Every forecast OrthoPediatrics put in an earnings release, newest first
| Given | Metric | Period | Guidance | Change |
|---|---|---|---|---|
| Oct 27, 2026 | adjusted EBITDA | FY2026 | $25.00M | Reaffirmed |
| Oct 27, 2026 | annual set deployment | FY2026 | $10.00M | New |
| Oct 27, 2026 | revenue guidance | FY2026 | $270.00M – $273.00M | Raised |
| Aug 4, 2026 | annual set deployment | FY2026 | $10.00M | New |
| Aug 4, 2026 | adjusted EBITDA | FY2026 | $25.00M | Reaffirmed |
| Aug 4, 2026 | growth over 2025 revenue | FY2026 | +12% – +14% | Raised |
| Aug 4, 2026 | revenue guidance | FY2026 | $265.00M – $269.00M | Raised |
| Apr 30, 2026 | adjusted EBITDA | FY2026 | $25.00M | Reaffirmed |
| Apr 30, 2026 | annual set deployment | FY2026 | $10.00M | New |
| Apr 30, 2026 | growth over 2025 revenue | FY2026 | +11% – +13% | Reaffirmed |
| Apr 30, 2026 | revenue guidance | FY2026 | $263.00M – $267.00M | Raised |
| Feb 26, 2026 | annual set deployment | FY2026 | $10.00M | New |
| Feb 26, 2026 | adjusted EBITDA | FY2026 | $25.00M | New |
| Feb 26, 2026 | revenue | FY2026 | $262.00M – $266.00M | New |
| Jan 12, 2026 | Adjusted EBITDA | FY2026 | $25.00M | New |
| Jan 12, 2026 | revenue growth | FY2026 | +11% – +13% | New |
| Jan 12, 2026 | revenue | FY2026 | $262.00M – $266.00M | New |
| Oct 28, 2025 | adjusted EBITDA | FY2025 | $15.00M – $17.00M | Reaffirmed |
| Oct 28, 2025 | annual set deployment | FY2025 | $15.00M | Reaffirmed |
| Oct 28, 2025 | revenue | FY2025 | $233.50M – $234.50M | Lowered |
| Oct 9, 2025 | adjusted EBITDA | FY2025 | $15.00M – $17.00M | New |
| Oct 9, 2025 | annual set deployment | FY2025 | $15.00M | New |
| Oct 9, 2025 | revenue growth | FY2025 | +14% – +15% | New |
| Oct 9, 2025 | revenue | FY2025 | $233.50M – $234.50M | New |
| Aug 5, 2025 | adjusted EBITDA | FY2025 | $15.00M – $17.00M | Reaffirmed |
| Aug 5, 2025 | annual set deployment | FY2025 | $15.00M | Reaffirmed |
| Aug 5, 2025 | revenue guidance growth | FY2025 | +16% – +18% | Raised |
| Aug 5, 2025 | revenue guidance | FY2025 | $237.00M – $242.00M | Raised |
| May 7, 2025 | adjusted EBITDA | FY2025 | $15.00M – $17.00M | Reaffirmed |
| May 7, 2025 | annual set deployment | FY2025 | $15.00M | Reaffirmed |
| May 7, 2025 | growth | FY2025 | +15% – +18% | Reaffirmed |
| May 7, 2025 | revenue guidance | FY2025 | $236.00M – $242.00M | Raised |
| Mar 4, 2025 | adjusted EBITDA | FY2025 | $15.00M – $17.00M | Reaffirmed |
| Mar 4, 2025 | annual set deployment | FY2025 | $15.00M | Reaffirmed |
| Mar 4, 2025 | revenue | FY2025 | $235.00M – $242.00M | Reaffirmed |
| Jan 13, 2025 | adjusted EBITDA | FY2025 | $15.00M – $17.00M | New |
| Jan 13, 2025 | annual set deployment | FY2025 | $15.00M | New |
| Jan 13, 2025 | growth compared to full year 2024 preliminary unaudited net revenue | FY2025 | +15% – +18% | New |
| Jan 13, 2025 | revenue | FY2025 | $235.00M – $242.00M | New |
| Nov 6, 2024 | Adjusted EBITDA | FY2024 | $8.00M – $9.00M | Reaffirmed |
| Nov 6, 2024 | growth | FY2024 | +36% – +37% | New |
| Nov 6, 2024 | revenue guidance | FY2024 | $202.00M – $204.00M | Raised |
| Aug 5, 2024 | Adjusted EBITDA | FY2024 | $8.00M – $9.00M | Reaffirmed |
| Aug 5, 2024 | revenue guidance | FY2024 | $200.00M – $203.00M | Reaffirmed |
| May 6, 2024 | adjusted EBITDA | FY2024 | $8.00M – $9.00M | Reaffirmed |
| May 6, 2024 | revenue guidance | FY2024 | $200.00M – $203.00M | Raised |
| Mar 6, 2024 | adjusted EBITDA | FY2024 | $8.00M – $9.00M | New |
| Mar 6, 2024 | revenue | FY2024 | $197.00M – $200.00M | New |
| Nov 6, 2023 | adjusted EBITDA | FY2023 | $4.00M – $5.00M | Raised |
| Nov 6, 2023 | annual set deployments | FY2023 | $23.00M | Lowered |
| Nov 6, 2023 | revenue | FY2023 | $148.00M – $151.00M | Reaffirmed |
| Jul 31, 2023 | adjusted EBITDA | FY2023 | $3.00M – $4.00M | Reaffirmed |
| Jul 31, 2023 | annual set deployments | FY2023 | $25.00M | Reaffirmed |
| Jul 31, 2023 | revenue guidance | FY2023 | $148.00M – $151.00M | Reaffirmed |
| May 1, 2023 | adjusted EBITDA | FY2023 | $3.00M – $4.00M | Reaffirmed |
| May 1, 2023 | annual set deployment | FY2023 | $25.00M | Reaffirmed |
| May 1, 2023 | revenue guidance | FY2023 | $148.00M – $151.00M | Raised |
| Feb 28, 2023 | adjusted EBITDA | FY2023 | $3.00M – $4.00M | New |
| Feb 28, 2023 | annual set deployment | FY2023 | $25.00M | New |
| Feb 28, 2023 | revenue | FY2023 | $146.00M – $149.00M | New |
| Oct 31, 2022 | annual set deployment | FY2022 | $20.00M – $24.00M | Lowered |
| Oct 31, 2022 | full year revenue | FY2022 | $124.00M – $125.00M | New |
| Oct 31, 2022 | full year revenue, excluding recent acquisitions | FY2022 | $113.00M – $114.00M | Lowered |
| Aug 3, 2022 | annual set deployment | FY2022 | $24.00M – $26.00M | New |
| Aug 3, 2022 | full year revenue | FY2022 | $127.00M – $130.00M | Raised |
| Aug 3, 2022 | full year revenue, excluding recent acquisitions | FY2022 | $118.00M – $121.00M | New |
| May 4, 2022 | annual set deployment | FY2022 | $24.00M – $26.00M | New |
| May 4, 2022 | revenue | FY2022 | $122.00M – $125.00M | Raised |
| Mar 2, 2022 | total 2022 revenue | FY2022 | $118.00M – $121.00M | New |
| Nov 3, 2021 | revenue | FY2021 | $97.00M – $101.00M | New |
Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.
Press releases
Releases OrthoPediatrics filed with the SEC as exhibits to Form 8-K or 6-K
- Update
- Results
- Update
- Results
- Update
- Results
- Update
- Results
- Update
- Results
- Update
- Results
- Results
- Update
- Results
See a number that looks wrong?